Price (delayed)
$13.57
Market cap
$1.74B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.62
Enterprise value
$1.99B
NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose
There are no recent dividends present for NEO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.